<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01689597</url>
  </required_header>
  <id_info>
    <org_study_id>18501</org_study_id>
    <nct_id>NCT01689597</nct_id>
  </id_info>
  <brief_title>Epidural Morphine for Analgesia After Traumatic Vaginal Delivery</brief_title>
  <official_title>Efficacy of Two Doses of Epidural Morphine for Analgesia After Traumatic Vaginal Delivery: a Randomized, Double Blinded, Placebo-controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study intends to establish the efficacy of 2 different doses of epidural morphine&#xD;
      for pain management after perineal trauma when using multimodal analgesia as well as the&#xD;
      feasibility of conducting a larger randomized clinical trial. Women with traumatic vaginal&#xD;
      delivery will be randomized into 3 groups with 10 patients each and receive 2.5 mg epidural&#xD;
      morphine, 1.25 mg epidural morphine, or epidural saline. The primary outcome is total opioid&#xD;
      consumption for breakthrough pain in the first 24 hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Withdrawn - no participants enrolled&#xD;
  </why_stopped>
  <start_date type="Anticipated">September 2012</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total breakthrough opioid consumption</measure>
    <time_frame>First 24 hours after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain scores at rest</measure>
    <time_frame>At 6, 12, 24, and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores with movement</measure>
    <time_frame>At 6, 12, 24, and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of nausea/vomiting</measure>
    <time_frame>At 6, 12, 24, and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of pruritis</measure>
    <time_frame>At 6, 12, 24, and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of sedation</measure>
    <time_frame>At 6, 12, 24, and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first request for additional analgesia</measure>
    <time_frame>First 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with pain control</measure>
    <time_frame>At 24 and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery</measure>
    <time_frame>At 24 and 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antiemetic consumption</measure>
    <time_frame>First 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antipruritic medication consumption</measure>
    <time_frame>First 36 h after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid consumption</measure>
    <time_frame>First 36 h after delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Traumatic Vaginal Delivery</condition>
  <arm_group>
    <arm_group_label>Low dose epidural morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One dose of 1.25 mg epidural morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose epidural morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One dose of 2.5 mg epidural morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One dose of 10 ml saline administered through an epidural catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Comparison of different dosages of drug</description>
    <arm_group_label>High dose epidural morphine</arm_group_label>
    <arm_group_label>Low dose epidural morphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is 18 years or older&#xD;
&#xD;
          -  The patient is ASA 1-3&#xD;
&#xD;
          -  Gestation 37-42 weeks&#xD;
&#xD;
          -  The patient had a vaginal delivery&#xD;
&#xD;
          -  The patient received epidural analgesia for labor and delivery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient has refused to participate&#xD;
&#xD;
          -  The patient cannot give informed consent&#xD;
&#xD;
          -  The investigator has significant concerns for maternal or neonatal welfare&#xD;
&#xD;
          -  The patient has a history of allergy to opioids&#xD;
&#xD;
          -  The patient has a history of chronic opioid consumption&#xD;
&#xD;
          -  The patient has a history of narcotic abuse&#xD;
&#xD;
          -  The patient has an allergy to local anesthetics&#xD;
&#xD;
          -  The patient has a contraindication to taking NSAIDs or acetaminophen&#xD;
&#xD;
          -  The patient received combined spinal-epidural analgesia&#xD;
&#xD;
          -  The patient has a history of chronic pain&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sudha I Singh, MD FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Western Ontario, Canada</affiliation>
  </overall_official>
  <verification_date>September 2012</verification_date>
  <study_first_submitted>September 18, 2012</study_first_submitted>
  <study_first_submitted_qc>September 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2012</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

